Compound file · metabolic
Batch · 2026-05-08
AOD5mg · lyophilized

AOD-9604

hGH C-terminal fragment (176–191) · 5mg lyophilized

0% HPLC verified· Janoshik

AOD-9604 is a modified fragment of the C-terminal region of human growth hormone studied for lipolytic pathway research without binding affinity for the GH receptor.

Lab ledger

HPLC purity0%
Lab partnerJanoshik Analytical
Batch tested2026-05-08
Certificate of Analysis
View certificate
Price$58.00

Save 12% paying in crypto at checkout

This batch, in trace

98.7%

Batch · 2026-05-08

This compound, this batchJanoshik Analytical · HPLC
98.7%AOD-96042 MIN5 MIN8 MIN12 MIN

Structure

Amino acid
sequence.

16residues
3-letter notation

16-residue peptide. Full sequence elided for readability — downloadable on the certificate of analysis.

Modifications

  • 01N-terminal Tyr addition for stability
  • 02Disulfide bond between Cys-7 and Cys-14

Notes

Sourcing & handling

Sourcing & manufacturing

Manufactured in a GMP-audited facility (cGMP-compliant)

Storage & reconstitution

Lyophilized: stable at room temperature in original sealed vial. Reconstituted: refrigerate at 2–8°C and use within 21 days. Research use only.

Also in metabolic

Related compounds

Recent batches

The ledger,
open.

Every batch sent for independent HPLC analysis at Janoshik Analytical. Results published the moment they land — no editorial pass, no rounding.

Compound
Purity
Batch
COA
Cagrilintide
5mg · metabolic
99.0%
2026-06-02
Dihexa
15mg · cognitive
98.5%
2026-06-02
Tesamorelin
10mg · growth
99.2%
2026-05-30
Thymosin Alpha-1
5mg · recovery
99.1%
2026-05-30
Cerebrolysin
215mg · cognitive
99.4%
2026-05-28

Showing 5 of 24

Methodology